Stefanus Christian 22010111120009 Lap.KTI BAB 8

(1)

48

the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases. 2000; 31: 347–82

3. South East Asian Medical Information Center. Seamic health statistics 2000. 2001

4. Mongardon N, Max A, Bougle A, Pene F, Lemiale V, Charpentier J, et al. Epidemiology and outcome of severe pneumococcal pneumonia admitted to intensive care unit: a multicenter study. Critical care. 2012; 16(4): R155

5. WHO. Pneumonia. 2014. Available from:

www.who.int/mediacentre/factsheets/fs331/en/

6. Musher DM, Anna R. Thorner. Community-Acquired Pneumonia. The New England Journal Of Medicine. 2014: 371; 17

7. File TM. Community-Acquired Pneumonia. Lancet. 2003: 362; 1991

8. Brown JS. Community-Acquired Pneumonia. Clinical Medicine 2012, Vol 12, No 6: 538–543

9. Dharmadhikari V, Joseph T, Kulkarni A. Bacteriological and Clinical Profile of Community Acquired Pneumonia in Hospitalized Patients. International Journal of Pharma and Bio Sciences. 2013: 695–702

10. Farida H, Juliëtte A. Severin, M. Gasem MH, et al. Nasopharyngeal Carriage of Klebsiella pneumoniae and Other Gram-Negative Bacilli in Pneumonia-Prone Age Groups in Semarang, Indonesia. Journal of Clinical Microbiology. 2013: 1614–1616

(2)

12. Lawrence MT, McPhee JS, Papadakis AM. Diagnosis dan Terapi Kedokteran Penyakit Dalam. 1 ed. Jakarta: Salemba Medika; 2002. 100 - 10 p

13. Armitage K, Woodhead M. New guidelines for the management of adult community-acquired pneumonia. Current opinion in infectious diseases. 2007; 20(2): 170-6

14. Dahlan Z. Chapter Pneumonia in Buku Ajar Penyakit Dalam jilid II Edisi IV. Jakarta: Interna Publishing: 2014. 1608-1619

15. WHO. Pneumonia. 2014. Available from:

who.int/mediacentre/factsheets/fs310/en/

16. Mendel LA, Wuderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, et al. Infectious Disease Society Of America / American Thoracic Society Consensus Guidelines On The Management Of Community-Acquired Pneumonia In Adults. Clinical Infectious Disease. 2007; 44: 527-72

17. Ewig S, Welte T. Evaluation of guidelines for community-acquired pneumonia: a story of confounders, surprises and challenges. Eur Respir J. 2008; 32: 823-5

18. Rabbat A, Huchon GJ. Bacterial Pneumonia. Dalam: Albert RK, Spiro SG, Jett JR, Clinical Respiratory Medicine, second edition. Ontario: Mosby. 2004; 23: 273-287

19. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C. Infectious Diseases Society of America. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis. 2003; 37: 1405-1433

20. CDC. The Pink Book: Course Textbook - 12th Edition Second Printing. May 2012. Available from: cdc.gov/vaccines/pubs/pinkbook/pneumo.html

(3)

3. 2006; 177-190

23. Mandell LA. Pneumonia, In : Fauci AS, Kasper DL, Longo DL, eds, Harrison’s Principles of Internal Medicine, 17th ed, USA, The Mc Graw- Hill companies Inc. 2008; chapter 251

24. Sharma S, Maycher Bruce, Eschun Gregg. Radiological Imaging in Pneumonia. Recent Innovations Imaging of Bacterial Pneumonia; 2014. Available from: medscape.org/viewarticle/556344_2

25. Boersma WG, Daniels J, Löwenberg A, Boeve W-J, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respiratory medicine. 2006; 100(5): 926-32

26. Mandell LA, Wunderink R. Pneumonia. Harrison's Principles of Internal Medicine. 2. 18th Edition ed. Jakarta: Penerbit Buku Kedokteran EGC. 2006. 957 – 90 p

27. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia.N Engl J Med 1997; 336: 243–50

28. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al; American Thoracic Society. Guidelines for the management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001; 163: 1730-1754.

29. Blot SI, Rodriguez A, Solé-Violán, J, Blanquer J, Almirall J, and Rello J. Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia. Crit Care Med 2007; 35: 2509–2514

(4)

adults: update 2009. Thorax 2009; 64: iii1- iii55 doi: 10.1136/thx. 2009. 121434

31. Nair V, Niederman MS, Masani N, Fishbane S. Hyponatremia in community-acquired pneumonia. Mineola. American Journal of Nephrology. 2007; 27(2):184-190

32. Prasad R. Community Acquired Pneumonia: Clinical Manifestations. Uttar Pradesh. Supplement to JAPI 2012 VOL. 60: 10

33. Yamakawa S, et al. Recurrent Pneumonia with Unconsciousness. Yokohama, Japan. Journal of Internal Medicine 2002; 251: 278-279

34. Wyss M, Daouk RK. Creatine and Creatinine Metabolism. Massachusetts. Physiological Reviews Vol. 80, No. 3, July 2000: 1114

35. Khan FY, Sayed H. Rhabdomyolysis associated with Mycoplasma pneumoniae pneumonia. Doha, Qatar. Hong Kong Med J Vol 18 No 3, June 2012: 247-248

36. Blanco RJ, Zabalza M, Salcedo J, Roman SJ. Rhabdomyolysis as a results of

Streptococcus pneumoniae: report of a case and review. Spain. European Society of Clinical Microbiology and Infectious Diseases 2003 : 944-947 37. Mortron SE, Mathai M, Byrd RP, Fields CL, Toy TM. Influenza a Pneumonia

with Rhabdomyolysis. Johnson City. South Med J. 2001; 94 (1)

38. Garcia MC, Ebeo CT, Byrd RP Jr, Roy TM. Rhabdomyolysis associated with pneumococcal pneumonia: an early clinical indicator of increased morbidity?. Mountain Home. Tenn Med 2002 Feb; 95(2): 67-9.

(5)

Lampiran 1. Biodata Penulis

1. Identitas

Nama : Stefanus Christian Setiawan

NIM : 22010111120009

Tempat/tanggal lahir : Semarang, 18 Desember 1993 Jenis kelamin : Laki-Laki

Alamat : Jl. Kenconowungu 6 / 37, Semarang Nomor HP : 081227007702

E-mail : stchristians@yahoo.com 2. Riwayat Pendidikan Formal

1. SD : SD YSKI Lulus tahun : 2005

2. SMP : SMP Domenico Savio Lulus Tahun : 2008 3. SMA : SMA Karangturi Lulus Tahun : 2011 4. FK UNDIP : Masuk Tahun 2011

3. Keanggotaan Organisasi

(6)

(7)

(8)

Lampiran 4. Analisis Data SPSS

Crosstabs

**Jenis kelamin * Outcome**

**Usia * Outcome**

Crosstab

17 43 60

28.3% 71.7% 100.0%

21 52 73

28.8% 71.2% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Jenis kelamin Count

% within Jenis kelamin P

W Jenis kelamin

Total

Mati Sembuh

Outcome

Total

Crosstab

0 10 10

.0% 100.0% 100.0%

3 5 8

37.5% 62.5% 100.0%

4 14 18

22.2% 77.8% 100.0%

7 15 22

31.8% 68.2% 100.0%

11 18 29

37.9% 62.1% 100.0%

13 33 46

28.3% 71.7% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count % within Usia Count % within Usia Count % within Usia Count % within Usia Count % within Usia Count % within Usia Count % within Usia 15-24

Mati Sembuh

Outcome

(9)

**Demam * Outcome**

Crosstab

34 83 117

29.1% 70.9% 100.0%

4 12 16

25.0% 75.0% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Demam Count

% within Demam Ya

Tidak Demam

Total

Mati Sembuh

Outcome

Total

Chi-Square Tests

.114b 1 .736

.002 1 .966

.116 1 .733

1.000 .497

.113 1 .737

133 Pearson Chi-Square

Continuity Correctiona Likelihood Ratio Fisher's Exact Test Linear-by-Linear Association N of Valid Cases

Value df

Asymp. Sig. (2-sided)

Exact Sig. (2-sided)

Computed only for a 2x2 table a.

1 cells (25.0%) have expected count less than 5. The minimum expected count is 4.57.

b.

Risk Estimate

1.229 .370 4.080

1.162 .475 2.844

.946 .697 1.284

133 Odds Ratio for

Demam (Ya / Tidak) For cohort Outcome = Mati

For cohort Outcome = Sembuh

N of Valid Cases

Value Lower Upper

(10)

**Sakit kepala * Outcome**

Crosstab

9 29 38

23.7% 76.3% 100.0%

29 66 95

30.5% 69.5% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Sakit kepala Count

% within Sakit kepala Ya

Tidak Sakit kepala

Total

Mati Sembuh

Outcome

Total

.623b 1 .430

.333 1 .564

.637 1 .425

.526 .285

.618 1 .432

Value df

0 cells (.0%) have expected count less than 5. The minimum expected count is 10.86.

b.

Risk Estimate

.706 .297 1.679

.776 .407 1.481

1.098 .880 1.371

133 Odds Ratio for Sakit

kepala (Ya / Tidak) For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper

(11)

**Chill * Outcome**

Crosstab

7 21 28

25.0% 75.0% 100.0%

31 74 105

29.5% 70.5% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count % within Chill Count % within Chill Count % within Chill Ya

Tidak Chill

Total

Mati Sembuh

Outcome

Total

.222b 1 .638

.055 1 .814

.226 1 .634

.814 .415

.220 1 .639

Value df

b.

Risk Estimate

.796 .307 2.063

.847 .418 1.716

1.064 .831 1.362

133 Odds Ratio for Chill

(Ya / Tidak)

For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper

(12)

**Batuk * Outcome**

Crosstab

36 89 125

28.8% 71.2% 100.0%

2 6 8

25.0% 75.0% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Batuk Count

% within Batuk Ya

Tidak Batuk

Total

Mati Sembuh Outcome

Total

.053b 1 .818

.000 1 1.000

.055 1 .815

1.000 .588

.053 1 .818

Value df

b.

Risk Estimate

1.213 .234 6.296

1.152 .336 3.947

.949 .627 1.438

133 Odds Ratio for

Batuk (Ya / Tidak) For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper

(13)

**Sputum * Outcome**

Crosstab

25 66 91

27.5% 72.5% 100.0%

13 29 42

31.0% 69.0% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Sputum Count

% within Sputum Ya

Tidak Sputum

Total

Mati Sembuh

Outcome

Total

.171b 1 .680

.043 1 .836

.169 1 .681

.685 .414

.169 1 .681

Value df

b.

Risk Estimate

.845 .380 1.880

.888 .506 1.556

1.050 .827 1.334

133 Odds Ratio for

Sputum (Ya / Tidak) For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper

(14)

**Hemoptysis * Outcome**

**Dyspnea * Outcome**

Crosstab

0 12 12

.0% 100.0% 100.0%

38 83 121

31.4% 68.6% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Hemoptysis Count

% within Hemoptysis Ya

Tidak Hemoptysis

Total

Mati Sembuh

Outcome

Total

5.276b 1 .022

3.849 1 .050

8.542 1 .003

.019 .014

5.236 1 .022

Value df

b.

Risk Estimate

1.458 1.292 1.645

133 For cohort Outcome

= Sembuh N of Valid Cases

Value Lower Upper

(15)

**Pleuric pain * Outcome**

38 80 118

32.2% 67.8% 100.0%

0 15 15

.0% 100.0% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Dyspnea Count

% within Dyspnea Ya

Tidak Dyspnea

Total

Mati Sembuh

Outcome

Total

6.763b 1 .009

5.277 1 .022

10.839 1 .001

.006 .005

6.712 1 .010

Value df

b.

Risk Estimate

.678 .599 .768

133 For cohort Outcome

= Sembuh N of Valid Cases

Value Lower Upper

95% Confidence Interval

Crosstab

1 6 7

14.3% 85.7% 100.0%

37 89 126

29.4% 70.6% 100.0%

38 95 133

28.6% 71.4% 100.0% Count

% within Pleuric pain Count

% within Pleuric pain Ya

Tidak Pleuric

pain

Total

Mati Sembuh Outcome

(16)

**Penurunan kesadaran * Outcome**

.739b 1 .390

.185 1 .667

.840 1 .359

.673 .354

.733 1 .392

Value df

b.

Risk Estimate

.401 .047 3.447

.486 .078 3.047

1.213 .879 1.676

133 Odds Ratio for Pleuric

pain (Ya / Tidak) For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper 95% Confidence

Interval

Crosstab

17 10 27

63.0% 37.0% 100.0%

21 85 106

19.8% 80.2% 100.0%

38 95 133

28.6% 71.4% 100.0% Count

% within Penurunan kesadaran

Count

Mati Sembuh Outcome

(17)

**Profil klinik * Outcome**

19.634b 1 .000

17.576 1 .000

18.017 1 .000

.000 .000

19.486 1 .000

Value df

b.

Risk Estimate

6.881 2.754 17.190

3.178 1.967 5.136

.462 .280 .762

133 Odds Ratio for

Penurunan kesadaran (Ya / Tidak)

N of Valid Cases

Value Lower Upper

Crosstab

7 25 32

21.9% 78.1% 100.0%

31 68 99

31.3% 68.7% 100.0%

0 2 2

.0% 100.0% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Profil klinik Count

% within Profil klinik 1-3

Mati Sembuh Outcome

(18)

**Hemoglobin * Outcome**

1.868a 2 .393

2.446 2 .294

.441 1 .507

Likelihood Ratio Linear-by-Linear Association N of Valid Cases

Value df

2 cells (33.3%) have expected count less than 5. The minimum expected count is .57.

a.

Crosstab

25 66 91

27.5% 72.5% 100.0%

13 29 42

31.0% 69.0% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Hemoglobin Count

% within Hemoglobin Tidak

Normal Hemoglobin

Total

Mati Sembuh

Outcome

Total

.171b 1 .680

.043 1 .836

.169 1 .681

.685 .414

.169 1 .681

Value df

(19)

**Hematokrit * Outcome**

.845 .380 1.880

.888 .506 1.556

1.050 .827 1.334

133 Odds Ratio for

Hemoglobin (Tidak / Normal)

N of Valid Cases

Value Lower Upper

Crosstab

24 61 85

28.2% 71.8% 100.0%

14 34 48

29.2% 70.8% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Hematokrit

Count

% within Hematokrit

Count

% within Hematokrit Tidak

Normal Hematokrit

Total

Mati Sembuh

Outcome

Total

.013b 1 .909

.000 1 1.000

.013 1 .909

1.000 .531

.013 1 .909

Value df

(20)

**Eritrosit * Outcome**

Risk Estimate

.956 .437 2.087

.968 .555 1.688

1.013 .809 1.269

133 Odds Ratio for Hematokrit

(Tidak / Normal)

N of Valid Cases

Value Lower Upper

Crosstab

18 54 72

25.0% 75.0% 100.0%

20 33 53

37.7% 62.3% 100.0%

38 87 125

30.4% 69.6% 100.0%

Count

% within Eritrosit

Count

% within Eritrosit

Count

% within Eritrosit Tidak

Normal Eritrosit

Total

Mati Sembuh

Outcome

Total

2.340b 1 .126

1.777 1 .183

2.325 1 .127

.168 .092

2.322 1 .128

Value df

(21)

**Lekosit * Outcome**

.550 .255 1.188

.663 .390 1.124

1.205 .940 1.544

125 Odds Ratio for Eritrosit

(Tidak / Normal) For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper

Crosstab

26 67 93

28.0% 72.0% 100.0%

12 28 40

30.0% 70.0% 100.0%

38 95 133

28.6% 71.4% 100.0% Count

% within Lekosit

Count

% within Lekosit

Count

% within Lekosit Tidak

Normal Lekosit

Total

Mati Sembuh Outcome

Total

.057b 1 .811

.001 1 .976

.057 1 .811

.836 .483

.057 1 .812

Value df

(22)

**Trombosit * Outcome**

Risk Estimate

.905 .401 2.043

.932 .524 1.656

1.029 .810 1.307

133 Odds Ratio for Lekosit

N of Valid Cases

Value Lower Upper

Crosstab

20 44 64

31.3% 68.8% 100.0%

18 51 69

26.1% 73.9% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Trombosit

Count

% within Trombosit

Count

% within Trombosit Tidak

Normal Trombosit

Total

Mati Sembuh Outcome

Total

.434b 1 .510

.218 1 .641

.434 1 .510

.567 .320

.430 1 .512

Value df

(23)

**Ureum * Outcome**

1.288 .606 2.737

1.198 .699 2.052

.930 .749 1.155

133 Odds Ratio for Trombosit

(Tidak / Normal)

N of Valid Cases

Value Lower Upper

Crosstab

28 57 85

32.9% 67.1% 100.0%

10 38 48

20.8% 79.2% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Ureum

Count

% within Ureum

Count

% within Ureum Tidak

Normal Ureum

Total

Mati Sembuh Outcome

Total

2.204b 1 .138

1.650 1 .199

2.273 1 .132

.164 .098

2.187 1 .139

Value df

(24)

**Kreatinin * Outcome**

Risk Estimate

1.867 .814 4.283

1.581 .843 2.967

.847 .688 1.043

133 Odds Ratio for Ureum

N of Valid Cases

Value Lower Upper

Crosstab

21 26 47

44.7% 55.3% 100.0%

17 69 86

19.8% 80.2% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Kreatinin

Count

% within Kreatinin

Count

% within Kreatinin Tidak

Normal Kreatinin

Total

Mati Sembuh Outcome

Total

9.243b 1 .002

8.062 1 .005

9.005 1 .003

.004 .002

9.173 1 .002

Value df

(25)

**GD sewaktu * Outcome**

3.278 1.499 7.169

2.260 1.328 3.846

.689 .522 .910

133 Odds Ratio for Kreatinin

N of Valid Cases

Value Lower Upper

Crosstab

12 38 50

24.0% 76.0% 100.0%

26 57 83

31.3% 68.7% 100.0%

38 95 133

28.6% 71.4% 100.0% Count

% within GD sewaktu

Count

% within GD sewaktu

Count

% within GD sewaktu Tidak

Normal GD sewaktu

Total

Mati Sembuh Outcome

Total

.820b 1 .365

.501 1 .479

.833 1 .361

.431 .241

.814 1 .367

Value df

(26)

**Natrium * Outcome**

Risk Estimate

.692 .312 1.537

.766 .426 1.378

1.107 .894 1.369

133 Odds Ratio for GD

sewaktu (Tidak / Normal) For cohort Outcome = Mati

N of Valid Cases

Value Lower Upper

Crosstab

21 46 67

31.3% 68.7% 100.0%

17 49 66

25.8% 74.2% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Natrium

Count

% within Natrium

Count

% within Natrium Tidak

Normal Natrium

Total

Mati Sembuh Outcome

Total

.508b 1 .476

.271 1 .602

.509 1 .476

.566 .301

.504 1 .478

Value df

(27)

**Kalium * Outcome**

1.316 .618 2.801

1.217 .708 2.092

.925 .746 1.147

133 Odds Ratio for Natrium

N of Valid Cases

Value Lower Upper

Crosstab

13 42 55

23.6% 76.4% 100.0%

25 53 78

32.1% 67.9% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Kalium

Count

% within Kalium

Count

% within Kalium Tidak

Normal Kalium

Total

Mati Sembuh Outcome

Total

1.119b 1 .290

.745 1 .388

1.134 1 .287

.333 .195

1.111 1 .292

Value df

(28)

**Khlorida * Outcome**

Risk Estimate

.656 .300 1.436

.737 .415 1.310

1.124 .909 1.389

133 Odds Ratio for Kalium

N of Valid Cases

Value Lower Upper

Crosstab

21 32 53

39.6% 60.4% 100.0%

17 63 80

21.3% 78.8% 100.0%

38 95 133

28.6% 71.4% 100.0%

Count

% within Khlorida

Count

% within Khlorida

Count

% within Khlorida Tidak

Normal Khlorida

Total

Mati Sembuh Outcome

Total

5.273b 1 .022

4.411 1 .036

5.206 1 .023

.031 .018

5.233 1 .022

Value df

(29)

**Kalsium * Outcome**

2.432 1.128 5.242

1.865 1.090 3.190

.767 .599 .981

133 Odds Ratio for Khlorida

N of Valid Cases

Interval

Crosstab

16 41 57

28.1% 71.9% 100.0%

15 34 49

30.6% 69.4% 100.0%

31 75 106

29.2% 70.8% 100.0% Count

% within Kalsium

Count

% within Kalsium

Count

% within Kalsium Tidak

Normal Kalsium

Total

Mati Sembuh Outcome

Total

.082b 1 .774

.005 1 .942

.082 1 .774

.832 .470

.082 1 .775

Value df

(30)

Logistic Regression

Risk Estimate

.885 .382 2.046

.917 .507 1.657

1.037 .810 1.327

106 Odds Ratio for Kalsium

N of Valid Cases

Interval

Case Processing Summary

133 100.0

0 .0

133 100.0

0 .0

133 100.0 Unweighted Casesa

Included in Analysis Missing Cases Total

Selected Cases

Unselected Cases Total

N Percent

If weight is in effect, see classification table for the total number of cases.

(31)

Block 0: Beginning Block

0 1 Original Value

Sembuh Mati

Internal Value

Categorical Variables Codings

53 .000

80 1.000

118 .000

15 1.000

27 .000

106 1.000

47 .000

86 1.000

12 .000

121 1.000 Tidak

Frequency (1) Paramete

r coding

Classification Tablea,b

95 0 100.0

Overall Percentage Step 0

Sembuh Mati

Outcome _Percentage Correct Predicted

Constant is included in the model. a.

The cut value is .500 b.

Variables in the Equation

-.916 .192 22.789 1 .000 .400

Constant Step 0

(32)

Block 1: Method = Enter

Variables not in the Equation

5.276 1 .022

6.763 1 .009

19.634 1 .000

9.243 1 .002

5.273 1 .022

33.940 5 .000

HEMOP(1)

Overall Statistics Step

0

Score df Sig.

Omnibus Tests of Model Coefficients

41.355 5 .000

Step Block Model Step 1

Chi-square df Sig.

Model Summary

117.784 .267 .383

Step 1

-2 Log likelihood

Cox & Snell R Square

Nagelkerke R Square

Classification Tablea

88 7 92.6

Sembuh Mati

Outcome _Percentage

Correct Predicted

The cut value is .500 a.

20.094 10479.2 .000 1 .998 5.E+08 .000 .

-20.128 9659.54 .000 1 .998 .000 .000 .

-1.646 .522 9.924 1 .002 .193 .069 .537

-1.106 .459 5.810 1 .016 .331 .135 .813

-.554 .457 1.466 1 .226 .575 .235 1.409

-18.511 10479.2 .000 1 .999 .000

HEMOP(1)

B S.E. Wald df Sig. Exp(B) Lower Upper

95.0% C.I.for EXP(B)

(33)

Logistic Regression

Block 0: Beginning Block

Case Processing Summary

133 100.0

0 .0

133 100.0

0 .0

133 100.0

Unweighted Casesa

Included in Analysis Missing Cases Total

Selected Cases

Unselected Cases Total

N Percent

If weight is in effect, see classification table for the total number of cases.

a.

Dependent Variable Encoding

0 1 Original Value

Sembuh Mati

Internal Value

Categorical Variables Codings

47 .000

86 1.000

27 .000

106 1.000

Tidak Normal Kreatinin

Ya Tidak Penurunan

kesadaran

Frequency (1) Paramete

(34)

Block 1: Method = Enter

Classification Tablea,b

95 0 100.0

Sembuh Mati

Outcome _Percentage

Correct Predicted

Constant is included in the model. a.

The cut value is .500 b.

-.916 .192 22.789 1 .000 .400

Constant Step 0

B S.E. Wald df Sig. Exp(B)

Variables not in the Equation

19.634 1 .000

9.243 1 .002

24.938 2 .000

TK(1) KREAT(1) Variables

Overall Statistics Step

0

Score df Sig.

Omnibus Tests of Model Coefficients

23.951 2 .000

Step Block Model Step 1

Chi-square df Sig.

Model Summary

135.188 .165 .236

Step 1

-2 Log likelihood

Cox & Snell R Square

Nagelkerke R Square

Classification Tablea

85 10 89.5

Sembuh Mati

Outcome _Percentage

Correct Predicted

(35)

-1.818 .481 14.306 1 .000 .162 .063 .416

-1.042 .428 5.918 1 .015 .353 .152 .817

1.068 .474 5.077 1 .024 2.908

TK(1) KREAT(1) Constant Step

1a

B S.E. Wald df Sig. Exp(B) Lower Upper

95.0% C.I.for EXP(B)